Millions • 14.7% constant currency organic Strong Balance Sheet for Future Capital Deployment Opportunities • No near-term debt maturities, no balance outstanding on revolver 25 *Net debt is total debt minus cash in $ billions; leverage ratio is principal debt minus cash to TTM adjusted EBITDA Introduction Results Driven 26 • Purpose Driven, Results Driven ...with Leadership Across the Continuum of Care SUP 23 24 • Stability in NovaSure Non-COVID Panther Utilization Metrics • Panther non-COVID utilization g ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HO ...

3 Introduction Elevating Global Women's Health… • 4th for large companies in San Diego County by The San Diego Union-Tribune 2 Non-GAAP Financial Measures The Company has presented the following non-GAAP financial measures in this presentation: constant currency revenues; organic revenues; non-GAAP gross margin; non-GAAP operating expenses; non-GAAP operating margin; non-GAAP effective tax rate; non-GAAP net income; non-GAAP net margin; non-GAAP EPS; and adjusted EBITDA. Constant currency calculations show ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 24, 2022 or For the transition period from to Commission File Number: 1-36214 __________________________________________________________ Securities registered pursuant to Section 12(b) of the Act: HOLOGIC, INC. (Exact ...

Hologic, Inc. (NASDAQ:HOLX) Q4 2022 Earnings Conference Call October 31, 2022 4:30 PM ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President and CEO Karleen Oberton - CFO Conference Call Participants Patrick Donnelly - Citi Tejas Savant - Morgan Stanley Anthony Petrone - Mizuho Group Jack Meehan - Nephron Research Puneet Souda - SVB Securities Liza Garcia - UBS Max Masucci - Cowen and Company Tim Daley - Wells Fargo Derik de Bruin - Bank of America Casey Woodring - JPMorgan Oper ...

Hologic, Inc. (NASDAQ:HOLX) Q3 2022 Results Earnings Conference Call July 28, 2022 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Tejas Savant - Morgan Stanley Patrick Donnelly - Citigroup Nisarg Shah - Bank of America Merrill Lynch Vijay Kumar - Evercore ISI Joseph Conway - Needham & Company Puneet Souda - ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 25, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HOLOGIC, ...

Hologic, Inc. (NASDAQ:HOLX) Q2 2022 Earnings Conference Call April 27, 2022 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Steve MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Vijay Kumar - Evercore ISI Patrick Donnelly - Citi Puneet Souda - SVB Securities Tejas Savant - Morgan Stanley Casey Woodring - JPMorgan Derik de Bruin - Bank of America Ryan Zimmerman - B ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 26, 2022 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HOLOGIC ...

| --- | --- | --- | |---------------------------------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | Growing Stronger by Delivering on Our Purpose, Passion and Promise | | | | February 2022 | | | Safe Harbor Statement 2 This presentation contains forward-looking information that involves risks and uncertainties, including statements about the Company's plans, objectives, expectations and intentions. Such statements include, without limitation: financial or other info ...